LPL Financial LLC lowered its holdings in Stereotaxis, Inc. (NYSEAMERICAN:STXS – Free Report) by 66.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,750 shares of the company’s stock after selling 22,934 shares during the quarter. LPL Financial LLC’s holdings in Stereotaxis were worth $27,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also modified their holdings of the company. Jane Street Group LLC increased its stake in shares of Stereotaxis by 26.9% in the third quarter. Jane Street Group LLC now owns 29,773 shares of the company’s stock valued at $61,000 after buying an additional 6,313 shares in the last quarter. SG Americas Securities LLC grew its position in shares of Stereotaxis by 39.2% in the 4th quarter. SG Americas Securities LLC now owns 26,360 shares of the company’s stock valued at $60,000 after purchasing an additional 7,417 shares during the period. Wealth Effects LLC lifted its position in Stereotaxis by 11.7% in the 4th quarter. Wealth Effects LLC now owns 86,060 shares of the company’s stock valued at $196,000 after acquiring an additional 9,000 shares in the last quarter. Kovack Advisors Inc. grew its holdings in shares of Stereotaxis by 8.0% during the fourth quarter. Kovack Advisors Inc. now owns 133,792 shares of the company’s stock worth $305,000 after buying an additional 9,917 shares in the last quarter. Finally, Bank of New York Mellon Corp lifted its position in shares of Stereotaxis by 13.0% in the fourth quarter. Bank of New York Mellon Corp now owns 193,109 shares of the company’s stock worth $440,000 after purchasing an additional 22,280 shares in the last quarter. Institutional investors own 45.35% of the company’s stock.
Stereotaxis Trading Up 1.0 %
Shares of STXS opened at $2.02 on Friday. The company has a market cap of $171.15 million, a price-to-earnings ratio of -7.21 and a beta of 1.54. The company’s fifty day simple moving average is $1.90 and its 200 day simple moving average is $2.07. Stereotaxis, Inc. has a 1-year low of $1.54 and a 1-year high of $2.72.
Insider Buying and Selling
Stereotaxis Company Profile
Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.
Further Reading
- Five stocks we like better than Stereotaxis
- With Risk Tolerance, One Size Does Not Fit All
- The Most Inspiring Small Businesses of 2025 [Survey]
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Microsoft Crushes Earnings, What’s Next for MSFT Stock?
- What Is WallStreetBets and What Stocks Are They Targeting?
- McDonald’s Insiders Sell Shares! Investors Should Do the Opposite
Receive News & Ratings for Stereotaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stereotaxis and related companies with MarketBeat.com's FREE daily email newsletter.